Bausch Health Companies Inc (BHC)
Health Care ยท Pharmaceutical Preparations
Bausch Health Companies Inc (BHC) is listed on the New York Stock Exchange, where its shares have traded since March 31, 1994. SentiSense covers Bausch Health Companies Inc in the Health Care sector, and its Standard Industrial Classification is Pharmaceutical Preparations. Thomas J. Appio is its chief executive officer. The company reports 20,300 employees, and its corporate website is www.bauschhealth.com.
About Bausch Health Companies Inc
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.
Latest reported results
Bausch Health Companies Inc. reported revenue of $2.94 billion for Q3 FY2026, up 9.7% from the same period a year earlier.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 214 institutions reported holding BHC, with 237.1 million shares worth $1.2 billion in aggregate. The largest reported holders were Paulson &, Goldentree Asset Management and Vanguard. Of the 5 largest reported holders, 1 added shares, 1 reduced its position and 3 held their positions unchanged during the quarter.
More on BHC
- BHC sentiment: whether news and social coverage of Bausch Health Companies Inc leans bullish or bearish, and the stories driving it.
- BHC ownership: all 214 reporting institutions, plus insider and congressional trades.
- BHC financials: revenue, net income, operating margin and free cash flow through Q3 FY2026.
SentiSense also tracks daily options readings for Bausch Health Companies Inc: IV rank, put/call percentile, 25-delta skew and open-interest walls.
Frequently asked questions
What does Bausch Health Companies Inc do?
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets.
What sector is BHC in?
SentiSense classifies Bausch Health Companies Inc in the Health Care sector, and its Standard Industrial Classification is Pharmaceutical Preparations.
Where does BHC stock trade?
Bausch Health Companies Inc (BHC) is listed on the New York Stock Exchange, where its shares have traded since March 31, 1994.
Who is the CEO of Bausch Health Companies Inc?
Thomas J. Appio is the chief executive officer of Bausch Health Companies Inc.